Narendran

Provectus Biopharmaceuticals Announces Presentation of Preclinical PV-10 Vaccine Adjuvant Data at Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting

Retrieved on: 
Monday, November 6, 2023
Vaccine, Cumming School of Medicine, Society for Immunotherapy of Cancer, MD, Cytokine, The central science, Doctor of Philosophy, Research, OTCQB, T cell, SITC, Immunotherapy, Vaccination, Disease, Chemokine, University, Narendran, Society

This research has been led by Aru Narendran, MD, PhD and his lab team from the Cumming School of Medicine at the University of Calgary in Alberta, Canada.

Key Points: 
  • This research has been led by Aru Narendran, MD, PhD and his lab team from the Cumming School of Medicine at the University of Calgary in Alberta, Canada.
  • Dr. Narendran and his colleagues previously discovered that PV-10 activated stimulator of interferon (IFN) genes (STING), demonstrating its potential as a vaccine adjuvant in PV-10-mediated systemic anti-tumor immune responses.
  • See Thakur et al., American Association for Cancer Research 2020 Virtual Annual Meeting II .
  • In its SITC work, the Narendran lab showed that PV-10 treatment induced STING activation, upregulated cytokines and chemokines, and increased IFN-γ secretion by CD8+ T-cells.

Provectus Biopharmaceuticals Expands Sponsored Research Collaboration with University of Calgary (Canada) to Investigate Systemic Administration of Pharmaceutical-Grade Rose Bengal for Treatment of Pediatric Leukemia

Retrieved on: 
Wednesday, August 17, 2022
U.S. Securities and Exchange Commission, Narendran, Dermatology, Physiology, Molecular biology, Hematology, Cumming School of Medicine, Evaluation, Drug discovery, NIH, Forward-looking statement, Legislation, GLOBE, IL, SEC, Microbiology, Pharmacology, Medicine, National, Security (finance), Research, Science Publishing Group, Epson HX-20, Company, P.O, WNK1, Dimer, Virology, Safety, Doctor of Philosophy, OTCQB, Immunotherapy, Completeness, Ophthalmology, University, MD, HX, Biochemistry, Association, Pharmaceutical industry, Risk management, Pediatrics, Oncology

The Companys innovatively-assembled and proprietary rose bengal is the lead member of a class of small molecules called halogenated xanthenes.

Key Points: 
  • The Companys innovatively-assembled and proprietary rose bengal is the lead member of a class of small molecules called halogenated xanthenes.
  • Provectus Biopharmaceuticals, Inc. (Provectus or the Company) is a clinical-stage biotechnology company developing immunotherapy medicines for different disease areas based on a class of small molecules called halogenated xanthenes (HXs).
  • Due to the risks, uncertainties, and assumptions inherent in forward-looking statements, readers should not place undue reliance on these forward-looking statements.
  • Risks, uncertainties, and assumptions include those discussed in the Companys filings with the Securities and Exchange Commission (SEC), including those described in Item 1A of:

Softtek Earns 2022 Great Place to Work® Certification in India

Retrieved on: 
Tuesday, July 19, 2022
High trust and low trust societies, Digital technology, QA, Feedback, Twitter, Instagram, Ideation, Social media, Research, ALL, Solution, Institute, India Inc., Organization, Leadership, Facebook, FOR, Review, Technology, Chief executive officer, Government, CXO, LinkedIn, Softtek, Employment, Narendran, Public relations, Renewable energy, Management

BANGALORE, India , July 19, 2022   /PRNewswire-PRWeb/ -- Softtek, a global company dedicated to helping organizations evolve through digital technology, has been Great Place to Work-Certified™ in India from June 2022 to June 2023. The recognition is a testament to Softtek's ongoing commitment to providing a fair, trustworthy, innovative and caring culture.

Key Points: 
  • Global provider of digital solutions is recognized for excelling in credibility, respect, fairness, pride and camaraderie
    BANGALORE, India, July 19, 2022 /PRNewswire-PRWeb/ -- Softtek , a global company dedicated to helping organizations evolve through digital technology, has been Great Place to Work-Certified in India from June 2022 to June 2023.
  • Great Place to Work is the global authority on workplace culture.
  • Hundreds of CEOs and CXOs from India Inc. are part of the great place community that is committed to the vision of making India a great place to work FOR ALLTM.
  • Their leaders believe in the vision of creating and sustaining a Great Place to Work FOR ALL and role model being 'FOR ALL' Leaders.

Atanu Mukherjee Takes Over as President & CEO of M N Dastur & Co. Pvt Ltd, Firm Expands Offerings Into Energy, Sustainability and Operations Improvement

Retrieved on: 
Tuesday, March 3, 2020
Natural Resources, Manufacturing, Mining, Minerals, Steel, States and union territories of India, BSE SENSEX, CNX Nifty, Narendran, Tata Steel, Dastur, Economy of India, India

Atanu has been the principal architect of the company's transition into energy, environment, new materials, digital and operations businesses.

Key Points: 
  • Atanu has been the principal architect of the company's transition into energy, environment, new materials, digital and operations businesses.
  • With an unparalleled legacy in steel, metals and mining since 1955, MN Dastur & Co Pvt.
  • Rustam M Dastur, current Chairman of the Board and Managing Director, will continue in his role guiding the organization and supporting Atanu in this transition.
  • T V Narendran, CEO & Managing Director, Tata Steel Limited, said, Tata Steel has had a long and cherished relationship with M N Dastur & Co. for many decades.

Discover Why it's Time to Revolutionize the Role of the Chief Innovation Officer at the 13th Annual New Product Innovation & Development: A Frost & Sullivan Executive MindXchange

Retrieved on: 
Thursday, December 6, 2018
Narendran, Transformation, Keynote, Agile, Culture

His keynote will cover the evolving and revolutionary ways to view and commit to this critical agent of transformation for success in the marketplace.

Key Points: 
  • His keynote will cover the evolving and revolutionary ways to view and commit to this critical agent of transformation for success in the marketplace.
  • This session will explore the benefits of becoming an Agile organization, as opposed to a traditional one.
  • Narendran will examine whether "Agile" is just a buzzword and share his cross-industry expertise on overcoming hurdles, celebrating victories, and defining benchmarks.
  • For additional information, please email: [email protected] or call Matthew McSweegan at 516-255-3812.

Discover Why it's Time to Revolutionize the Role of the Chief Innovation Officer at the 13th Annual New Product Innovation & Development: A Frost & Sullivan Executive MindXchange

Retrieved on: 
Thursday, December 6, 2018
Narendran, Transformation, Keynote, Agile, Culture

His keynote will cover the evolving and revolutionary ways to view and commit to this critical agent of transformation for success in the marketplace.

Key Points: 
  • His keynote will cover the evolving and revolutionary ways to view and commit to this critical agent of transformation for success in the marketplace.
  • This session will explore the benefits of becoming an Agile organization, as opposed to a traditional one.
  • Narendran will examine whether "Agile" is just a buzzword and share his cross-industry expertise on overcoming hurdles, celebrating victories, and defining benchmarks.
  • For additional information, please email: [email protected] or call Matthew McSweegan at 516-255-3812.